📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
In 2024, Excelsior Medical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Excelsior Medical has also provided a category-level breakdown for 4 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Excelsior Medical’s data sources below and access millions more through our Disclosure Search.
In 2024, the total operational greenhouse gas (GHG) emissions ofExcelsior Medical amounted to251.883metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Excelsior Medicalincreased by 0%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2024, the total Scope 1 emissions of Excelsior Medical were 42.226 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Compared to the previous year(2023), Excelsior Medical's Scope 1 emissions decreased by 13.54%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2024, Excelsior Medical reported Scope 2 greenhouse gas (GHG) emissions of 209.656 tCOâ‚‚e without specifying the calculation method.a
Compared to the previous year(2023), Excelsior Medical's Scope 2 emissions(Unspecified Calculation Method) have remained relatively stable, indicating that Excelsior Medical's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2024, Excelsior Medical reported its Scope 2 emissions using an unspecified methodology.a
In 2024, Excelsior Medical reported 531.729 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Excelsior Medical includes a breakdown across 4of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, Excelsior Medical reported total Scope 3 emissions of 531.729 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 100%of these emissions originated from upstream activities such as purchased goods and capital goods, while 0%came from downstream activities like product use, distribution, and end-of-life treatment.a
Compared to the previous year (2023), Excelsior Medical's Scope 3 emissions remained relatively stable, indicating that Excelsior Medical's emissions have plateaued with no significant change in its value chain footprint.a
In 2024, Excelsior Medical reported emissions for 4 out of the 15 Scope 3 categories defined by the GHG Protocol.a
The limited disclosure restricts visibility into specific emission sources across the company's value chain.
In 2024, the largest contributors to Excelsior Medical's Scope 3 emissions were:a
In 2024, Excelsior Medical reported Scope 1 greenhouse gas (GHG) emissions of 42.226 tCOâ‚‚e and total revenues of USD 261 millions. This translates into an emissions intensity of 0.16 tCOâ‚‚e per millions USD.a
In 2024, Excelsior Medical reported a Scope 1 emissions intensity of 0.16 tCOâ‚‚e per millions USD. Compared to the peer group median of 1.32, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2024, Excelsior Medical ranked 3 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
This places Excelsior Medical among the top performers, with one of the lowest emissions intensities relative to peers.a
In 2024, Excelsior Medical reported a total carbon footprint of 783.611 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 5.59% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Excelsior Medical's total carbon footprint was Scope 3 emissions, accounting for 67.86% of the company's total carbon footprint, followed by Scope 2 emissions at 26.76%.a